press releases rule

Archives: Search / 2015 / 2014 / 2013 / 2012 / 2011 / 2010 / 2009 / 2008

May 19, 2015
-- Company's Program for Prevention of C. difficile Infection in Phase 2a Clinical Trial and on Target for Phase 2b Clinical Trial Initiation in 2H 2015 --
May 18, 2015
-- Company's Irritable Bowel Syndrome with Constipation (IBS-C) Program to Reduce the Impact of Methane Gas in the Gut on Target to Initiate Phase 2 Clinical Trial in 2Q 2015 --
May 11, 2015
-- Initiated Phase 2 for Prevention of C. difficile, Expected to Initiate Phase 2 for IBS-C by end of June 2015, and Expanded Leadership Team as Company Moves into Next Development Stage --
May 7, 2015
-- Appointment Reflects Company's Expanded Clinical and Market Driven Focus --
May 4, 2015
-- Executive Brings Significant Biotech Industry Leadership Experience to Team as Company Enters Next Phase of Development --
 

Print Email RSS
print email rss